RAS inhibitors more renoprotective than CCBs in advanced chronic kidney disease
03 May 2021
byJairia Dela Cruz
In the treatment of patients with advanced chronic kidney disease, use of renin-angiotensin system (RAS) inhibitors slows the progression of kidney disease compared with calcium channel blockers (CCBs), although the two drugs offer similar cardiovascular protection, as shown in a study.